Cite
MLA Citation
T. Spelman et al.. “Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.” European journal of neurology, vol. 23, n.d., pp. 729–736. http://access.bl.uk/ark:/81055/vdc_100031255002.0x00001b